Inventor · disambiguated record
Jason A. Dubovsky
Also filed as: DUBOVSKY JASON · DUBOVSKY JASON A
6 granted patents·15 pending applications·109 citations·filing 2007–2024
86Inventor score
Top patents by PatentIndex Score
21 records- 0195US10357514B2Treatment of cancer using anti-CD19 Chimeric Antigen ReceptorUNIV PENNSYLVANIA·Filed 2015·Granted Jul 23, 2019·18 cites·45 claims
- 0294US10695350B2Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2019·Granted Jun 30, 2020·6 cites·8 claims
- 0393US9795604B2Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2014·Granted Oct 24, 2017·19 cites·55 claims
- 0491US10463668B2Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2017·Granted Nov 5, 2019·8 cites·4 claims
- 0591US9717731B2TEC family kinase inhibitor adjuvant therapyPHARMACYCLICS LLC·Filed 2013·Granted Aug 1, 2017·14 cites·6 claims
- 0690US7635753B2Prostate cancer and melanoma antigensWISCONSIN ALUMNI RES FOUND·Filed 2008·Granted Dec 22, 2009·44 cites·1 claims
- 0788US2025345335A1Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2024·Application pending·0 cites
- 0885US2024293408A1Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2023·Application pending·0 cites
- 0979US2023097340A1Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2022·Application pending·0 cites
- 1071US2021121463A1Methods of treating and preventing graft versus host diseasePHARMACYCLICS LLC·Filed 2020·Application pending·0 cites
- 1162US2019388471A1Treatment of cancer using anti-cd19 chimeric antigen receptorNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1262US2020147084A1Tec family kinase inhibitor adjuvant therapyPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 1359US2014371241A1Tec family kinase inhibitor adjuvant therapyPHARMACYCLICS INC·Filed 2014·Application pending·0 cites
- 1455US2018071293A1Tec family kinase inhibitor adjuvant therapyPHARMACYCLICS LLC·Filed 2017·Application pending·0 cites
- 1554US2010124755A1Prostate cancer and melanoma antigensMCNEEL DOUGLAS G·Filed 2009·Application pending·0 cites
- 1649US2022031746A1Methods for dosing and treatment of b cell malignancies in adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1744US2007232558A1Methods and compositions for treating prostate cancer using dna vaccines directed to cancer testis antigenMCNEEL DOUGLAS G·Filed 2007·Application pending·0 cites
- 1844US2023053787A1Methods related to toxicity and response associated with cell therapy for treating b cell malignanciesJUNO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1942US2021121466A1Combination therapy of a chimeric antigen receptor (car) t cell therapy and a kinase inhibitorJUNO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2041US2022249637A1Combination therapy of a cell-mediated cytotoxic therapy and an inhibitor of a prosurvival bcl2 family proteinJUNO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2133US2018140602A1Combination of chimeric antigen receptor therapy and amino pyrimidine derivativesANGST DANIELA·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jason A. Dubovsky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →